{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:50:47Z","timestamp":1782100247836,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007703","name":"North Carolina State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023993","name":"North Carolina Policy Collaboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014459","name":"Center for Human Heath and the Environment, North Carolina State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["1R21ES029353"],"award-info":[{"award-number":["1R21ES029353"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["U24ES037001"],"award-info":[{"award-number":["U24ES037001"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hygiene and Environmental Health"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijheh.2026.114755","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:45:19Z","timestamp":1770245119000},"page":"114755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum per- and polyfluoroalkyl substances (PFAS) concentrations and anti-spike SARS-CoV-2 IgG levels following COVID-19 vaccination: A cross-sectional study in three communities with elevated PFAS exposure"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6183-1620","authenticated-orcid":false,"given":"Sarah","family":"Rhea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3774-405X","authenticated-orcid":false,"given":"Michael","family":"Cuffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Suzanne","family":"Lea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kotlarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-0969","authenticated-orcid":false,"given":"Jane A.","family":"Hoppin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijheh.2026.114755_bib2","series-title":"PFAS Exposure Assessments Final Report: Findings Across 10 Exposure Assessment Sites","year":"2022"},{"key":"10.1016\/j.ijheh.2026.114755_bib3","series-title":"What Explains Temporal and Geographic Variation in the Early US Coronavirus Pandemic?","author":"Allcot","year":"2020"},{"key":"10.1016\/j.ijheh.2026.114755_bib4","article-title":"Safety and immunogenicity of mRNA-1010, an investigational seasonal influenza vaccine, in healthy adults: final results from a phase 1\/2 randomized trial","author":"Ananworanich","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ijheh.2026.114755_bib5","doi-asserted-by":"crossref","DOI":"10.1289\/EHP11847","article-title":"High exposure to perfluoroalkyl substances and antibody responses to SARS-CoV-2 mRNA Vaccine\u2014An observational study in adults from ronneby, Sweden","volume":"131","author":"Andersson","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijheh.2026.114755_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41370-023-00564-8","article-title":"Immune response to COVID-19 vaccination in a population with a history of elevated exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water","author":"Bailey","year":"2023","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"5","key":"10.1016\/j.ijheh.2026.114755_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijheh.2026.114755_bib8","article-title":"Anti-SARS-CoV-2 antibody levels measured by the AdviseDx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity","volume":"vol. 59","author":"Bradley","year":"2021"},{"issue":"4","key":"10.1016\/j.ijheh.2026.114755_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10408444.2015.1122573","article-title":"A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans","volume":"46","author":"Chang","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.ijheh.2026.114755_bib12","year":"2022"},{"issue":"2","key":"10.1016\/j.ijheh.2026.114755_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/vaccines10020153","article-title":"Decline of Anti-SARS-CoV-2 IgG antibody levels 6 months after complete BNT162b2 vaccination in healthcare workers to levels observed following the first vaccine dose","volume":"10","author":"\u0110akovi\u0107","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijheh.2026.114755_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106833","article-title":"Frontline workers and COVID-19 inequities","volume":"153","author":"Do","year":"2021","journal-title":"Prev. Med."},{"issue":"49","key":"10.1016\/j.ijheh.2026.114755_bib16","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.15585\/mmwr.mm6949e1","article-title":"The advisory committee on immunization practices' interim recommendation for allocating initial supplies of COVID-19 vaccine \u2014 united States, 2020","volume":"69","author":"Dooling","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"5152","key":"10.1016\/j.ijheh.2026.114755_bib17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.15585\/mmwr.mm695152e2","article-title":"The advisory committee on immunization practices\u2019 updated interim recommendation for allocation of COVID-19 vaccine - united States, December 2020","volume":"69","author":"Dooling","year":"2021","journal-title":"Morb. Mortal. Wkly. Rep."},{"issue":"11","key":"10.1016\/j.ijheh.2026.114755_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9295","article-title":"Development and validation of a high resolving power absolute quantitative per- and polyfluoroalkyl substances method incorporating skyline data processing","volume":"36","author":"Enders","year":"2022","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijheh.2026.114755_bib19","article-title":"Fact sheet for healthcare providers administering vaccine: emergency use authorization of the Janssen COVID-19 vaccine to prevent COVID-19","year":"2023"},{"key":"10.1016\/j.ijheh.2026.114755_bib20","series-title":"mRNA vaccines: not just for COVID soon? Medscape","author":"Fleck","year":"2024"},{"issue":"4","key":"10.1016\/j.ijheh.2026.114755_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.2034","article-title":"Serum vaccine antibody concentrations in children exposed to perfluorinated compounds","volume":"307","author":"Grandjean","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijheh.2026.114755_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal Diagrams for Epidemiologic Research","volume":"10","author":"Greenland","year":"1999","journal-title":"Epidemiology."},{"key":"10.1016\/j.ijheh.2026.114755_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.01.053","article-title":"The U.S. COVID-19 vaccination program: a look back and future directions","volume":"42","author":"Hall","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijheh.2026.114755_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.envint.2011.01.011","article-title":"Characterisation of human exposure pathways to perfluorinated compounds \u2014 comparing exposure estimates with biomarkers of exposure","volume":"37","author":"Haug","year":"2011","journal-title":"Environ. Int."},{"key":"10.1016\/j.ijheh.2026.114755_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117297","article-title":"Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies","volume":"239","author":"Hollister","year":"2023","journal-title":"Environ. Res."},{"issue":"6","key":"10.1016\/j.ijheh.2026.114755_bib26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jiac.2022.02.024","article-title":"Dynamics of Anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers","volume":"28","author":"Ikezaki","year":"2022","journal-title":"J. Infect. Chemother."},{"issue":"19","key":"10.1016\/j.ijheh.2026.114755_bib27","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.vaccine.2022.03.057","article-title":"Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination","volume":"40","author":"Kato","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijheh.2026.114755_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.115067","article-title":"Cross-sectional associations of maternal PFAS exposure on SARS-CoV-2 IgG antibody levels during pregnancy","volume":"219","author":"Kaur","year":"2023","journal-title":"Environ. Res."},{"issue":"2","key":"10.1016\/j.ijheh.2026.114755_bib29","first-page":"270","article-title":"Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates","volume":"13","author":"Kielsen","year":"2016","journal-title":"J. Immunot."},{"issue":"1","key":"10.1016\/j.ijheh.2026.114755_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41370-023-00626-x","article-title":"Per- and polyfluoroalkyl ether acids in well water and blood serum from private well users residing by a fluorochemical facility near Fayetteville, North Carolina","volume":"34","author":"Kotlarz","year":"2024","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"7","key":"10.1016\/j.ijheh.2026.114755_bib30","doi-asserted-by":"crossref","DOI":"10.1289\/EHP6837","article-title":"Measurement of novel, drinking water-associated PFAS in blood from adults and children in Wilmington, North Carolina","volume":"128","author":"Kotlarz","year":"2020","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.ijheh.2026.114755_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/toxsci\/kft269","article-title":"Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate","volume":"138","author":"Looker","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.ijheh.2026.114755_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13181","article-title":"Estimating SARS\u2010CoV\u20102 infections and associated changes in COVID\u201019 severity and fatality","volume":"17","author":"Marziano","year":"2023","journal-title":"Influenza Resp. Viruses"},{"issue":"5","key":"10.1016\/j.ijheh.2026.114755_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10650","article-title":"Evaluation of waning of SARS-CoV-2 vaccine\u2013induced immunity: a systematic review and meta-analysis","volume":"6","author":"Menegale","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijheh.2026.114755_bib35","series-title":"Vaccine Information Fact Sheet for Recipients and Caregivers About Spikevax (COVID-19 Vaccine, mRNA), Moderna Covid-19 Vaccine, and Moderna COVID-19 Vaccine, Bivalent (Original And Omicron Ba.4\/Ba.5) to Prevent COVID-19","year":"2022"},{"issue":"3","key":"10.1016\/j.ijheh.2026.114755_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/jiaa659","article-title":"Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients","volume":"223","author":"Muecksch","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijheh.2026.114755_bib37","article-title":"Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study","volume":"10","author":"Naaber","year":"2021","journal-title":"Lancet Reg. Health - Europe"},{"issue":"15","key":"10.1016\/j.ijheh.2026.114755_bib38","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/es070792y","article-title":"Perfluorinated compounds in the cape fear drainage basin in North Carolina","volume":"41","author":"Nakayama","year":"2007","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ijheh.2026.114755_bib39","article-title":"NTP monograph on immunotoxicity associated with exposure to perfluorooctanoic acid or perfluorooctane sulfonate","year":"2016","journal-title":"Natl. Insitut. Environ. Sci."},{"key":"10.1016\/j.ijheh.2026.114755_bib40","unstructured":"North Carolina State University. The GenX exposure study. GenX Exposure Study. Accessed September 5, 2023. https:\/\/genxstudy.ncsu.edu."},{"issue":"28","key":"10.1016\/j.ijheh.2026.114755_bib41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.15585\/mmwr.mm7028a1","article-title":"COVID-19 vaccination coverage among insured persons aged \u226516 years, by race\/ethnicity and other selected characteristics \u2014 eight integrated health care organizations, United States, December 14, 2020\u2013May 15, 2021","volume":"70","author":"Pingali","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.ijheh.2026.114755_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107537","article-title":"Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances","volume":"169","author":"Porter","year":"2022","journal-title":"Environ. Int."},{"issue":"7","key":"10.1016\/j.ijheh.2026.114755_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/ijerph14070691","article-title":"Exposure to perfluorinated alkyl substances and health outcomes in children: a systematic review of the epidemiologic literature","volume":"14","author":"Rappazzo","year":"2017","journal-title":"IJERPH"},{"issue":"12","key":"10.1016\/j.ijheh.2026.114755_bib44","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/vaccines11121813","article-title":"COVID-19 vaccination and immunosuppressive therapy in immune-mediated inflammatory diseases","volume":"11","author":"Serra L\u00f3pez-Matencio","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.ijheh.2026.114755_bib45","doi-asserted-by":"crossref","DOI":"10.1289\/EHP12971","article-title":"Invited perspective: per- and polyfluoroalkyl substances and impaired antibody response to vaccination\u2014who is affected?","volume":"131","author":"Starling","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijheh.2026.114755_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.envres.2016.05.020","article-title":"Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults","volume":"149","author":"Stein","year":"2016","journal-title":"Environ. Res."},{"issue":"1","key":"10.1016\/j.ijheh.2026.114755_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20747-x","article-title":"Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers","volume":"12","author":"Sugiyama","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijheh.2026.114755_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"1","key":"10.1016\/j.ijheh.2026.114755_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/epirev\/mxad010","article-title":"\u201cWe adjusted for race\u201d: now what? A systematic review of utilization and reporting of race in American Journal of Epidemiology and Epidemiology , 2020\u20132021","volume":"45","author":"Swilley-Martinez","year":"2023","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.ijheh.2026.114755_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyw341","article-title":"Robust causal inference using directed acyclic graphs: the R package \u2018dagitty.\u2019","author":"Textor","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ijheh.2026.114755_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2024.120039","article-title":"Antibody response to SARS-CoV-2 mRNA vaccination in Danish adults exposed to perfluoroalkyl substances (PFASs): the ENFORCE study","volume":"263","author":"Timmermann","year":"2024","journal-title":"Environ. Res."},{"issue":"9","key":"10.1016\/j.ijheh.2026.114755_bib52","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/vaccines11091496","article-title":"Strategies and trends in COVID-19 vaccination delivery: what we learn and what we may use for the future","volume":"11","author":"Tradigo","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.ijheh.2026.114755_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur. J. Epidemiol."},{"issue":"31","key":"10.1016\/j.ijheh.2026.114755_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe7733","article-title":"Interdependent program evaluation: geographic and social spillovers in COVID-19 closures and reopenings in the United States","volume":"7","author":"Zhao","year":"2021","journal-title":"Sci. Adv."}],"container-title":["International Journal of Hygiene and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463926000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463926000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:41:55Z","timestamp":1782099715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438463926000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"alternative-id":["S1438463926000155"],"URL":"https:\/\/doi.org\/10.1016\/j.ijheh.2026.114755","relation":{},"ISSN":["1438-4639"],"issn-type":[{"value":"1438-4639","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum per- and polyfluoroalkyl substances (PFAS) concentrations and anti-spike SARS-CoV-2 IgG levels following COVID-19 vaccination: A cross-sectional study in three communities with elevated PFAS exposure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Hygiene and Environmental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijheh.2026.114755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"114755"}}